Blann Andrew D, Lip Gregory Y H
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
Blood Coagul Fibrinolysis. 2003 Jun;14(4):335-40. doi: 10.1097/00001721-200306000-00003.
Increased levels of various plasma molecules, including C-reactive protein (CRP), and endothelial markers von Willebrand factor (vWF), E-selectin, intercellular adhesion molecule-1 (ICAM-1) and thrombomodulin all predict the development and/or progression of cardiovascular disease. As CRP has been shown to upregulate the expression of adhesion molecules on the surface of human umbilical vein endothelial cells (HUVECs) in vitro, we hypothesized that CRP would induce the release of increased levels of the endothelial markers from HUVECs. Accordingly, recombinant human CRP was added to the culture medium of confluent monolayers of HUVECs at physiological to pathological doses of 1-50 microg/ml for 3-48 h. Markers were measured in supernatants by commercial enzyme-linked immunosorbent assays. We found that increased release of thrombomodulin was induced by 20 and 50 microg/ml CRP after 48 h. Increased ICAM-1 was induced by 50 microg/ml CRP after 24 and 48 h. There was no clear influence of CRP on E-selectin, but 20 and 50 microg/ml CRP inhibited the release of vWF. Our data provide further evidence of a link between increased levels of ICAM-1, thrombomodulin and CRP in atherosclerosis, but they counter reports of a direct, possibly causal, relationship between CRP and increases in E-selectin or vWF.
包括C反应蛋白(CRP)在内的多种血浆分子以及内皮标志物血管性血友病因子(vWF)、E选择素、细胞间黏附分子-1(ICAM-1)和血栓调节蛋白水平的升高均预示着心血管疾病的发生和/或进展。由于体外实验已表明CRP可上调人脐静脉内皮细胞(HUVECs)表面黏附分子的表达,我们推测CRP会诱导HUVECs释放更多水平的内皮标志物。因此,将重组人CRP以1 - 50微克/毫升的生理至病理剂量添加到融合的HUVEC单层细胞培养基中,作用3 - 48小时。通过商业酶联免疫吸附测定法测量上清液中的标志物。我们发现,48小时后,20和50微克/毫升的CRP诱导血栓调节蛋白释放增加。24和48小时后,50微克/毫升的CRP诱导ICAM-1增加。CRP对E选择素没有明显影响,但20和50微克/毫升的CRP抑制vWF的释放。我们的数据进一步证明了动脉粥样硬化中ICAM-1、血栓调节蛋白和CRP水平升高之间的联系,但反驳了关于CRP与E选择素或vWF增加之间存在直接、可能因果关系的报道。